GGCPX | VTISX | GGCPX / VTISX | |
Total Expense Ratio | 0.90 | 0.05 | 1,915% |
Annual Report Gross Expense Ratio | 0.96 | 0.05 | 2,043% |
Fund Existence | 7 years | 9 years | - |
Gain YTD | 19.331 | 13.278 | 146% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 874M | 470B | 0% |
Annual Yield % from dividends | 1.93 | 3.07 | 63% |
Returns for 1 year | 16.98 | 10.00 | 170% |
Returns for 3 years | 46.07 | 24.57 | 187% |
Returns for 5 years | 90.61 | 53.09 | 171% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FPHAX | 23.31 | -0.06 | -0.26% |
Fidelity Select Pharmaceuticals Port | |||
RMBBX | 15.72 | -0.05 | -0.32% |
RMB Small Cap I | |||
SPINX | 19.64 | -0.13 | -0.66% |
SEI S&P 500 Index A (SIIT) | |||
FAFGX | 75.28 | -0.53 | -0.70% |
American Funds Growth Fund of Amer 529F2 | |||
BRWCX | 22.84 | -0.22 | -0.95% |
MFS Blended Research Growth Eq C |